Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07420257 Ocankitug Nasal Polyps Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07420257 clinical trial report covering Ocankitug, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07421297 SYH2053 Mixed hyperlipidemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07421297 clinical trial report covering SYH2053, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07419828 HRS-1780 Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07419828 clinical trial report covering HRS-1780, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07419295 Sacituzumab tirumotecan Bladder Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07419295 clinical trial report covering Sacituzumab tirumotecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07419334 Gildeuretinol acetate Stargardt Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07419334 clinical trial report covering Gildeuretinol acetate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07425392 31 Valent Pneumococcal Conjugate Vaccine(Vaxcyte) Pneumococcal Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07425392 clinical trial report covering 31 Valent Pneumococcal Conjugate Vaccine(Vaxcyte), Phase 3, endpoints, sponsor, geography, readout timing and de
Latest Hotspot
8 min read
NCT07423390 Mecobalamin Peripheral Nervous System Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07423390 clinical trial report covering Mecobalamin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07423156 Tranexamic Acid Hemorrhage Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07423156 clinical trial report covering Tranexamic Acid, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07424404 Xanomeline Tartrate/Trospium Chloride Autism Spectrum Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07424404 clinical trial report covering Xanomeline Tartrate/Trospium Chloride, Phase 3, endpoints, sponsor, geography, readout timing and development wh
Latest Hotspot
8 min read
NCT07424144 Itepekimab Chronic rhinosinusitis with nasal polyps Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07424144 clinical trial report covering Itepekimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
SLCTR/2026/005 Magnesium Sulfate Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
SLCTR/2026/005 clinical trial report covering Magnesium Sulfate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07422480 Elritercept Anemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07422480 clinical trial report covering Elritercept, Phase 3, endpoints, sponsor, geography, readout timing and development white space.